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Modernizing Colorectal Cancer Screening With Cologuard
Alaynna Kears DO, Arjan Ahluwalia MD, Maria Jones MD
Valley Health Partners, Allentown, PA

Background

Resident clinics typically experience low
colorectal cancer (CRC) screening completion
rates. CRC is the second leading cause of cancer
deaths in the United States making early
detection key for patient survival.
Endoscopic evaluation, the gold standard for
CRC screening, is fraught with logistical changes,
costs, and time commitment. Implementation of
Cologuard will lessen costs and ultimately
improve CRC screening.

Objective

To improve CRC screening in patients at our
Internal Medicine resident clinic to a goal of
60% or higher.

Methods

• Identified 1,130 patients who were currently
overdue for CRC screening at our clinic.
• Medical record was individually reviewed
and assessed for type of insurance, risk for
colorectal cancer, and previous outreach
attempts in regard to screening.
• Cologuard order placed for patients with
Medicare insurance or certain private
insurances who were average risk for CRC
screening.
• L etter sent to the patient explaining that
they were due for CRC screening and that
a Cologuard test had been ordered on
their behalf for them to complete.

Results

• Of the 283 patients for which a Cologuard order had
been placed, 67 patients (24%) completed the test kit
after 2 months.
• 13 patients (19%) had a positive result, 44 patients (66%)
had a negative result, and 10 patients (15%) had an
inadequate sample.
• Overall CRC screening rate at our clinic improved from
56.4% to 61%.
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Utilization of Cologuard testing improved our CRC
screening rates to above our goal of 60%.

Clinical Implications

• Covid-19 pandemic caused significant delay in
scheduling colonoscopies.
• Patients at our resident clinic decline endoscopic
evaluation secondary to cost, transportation
issues, low health literacy, and intolerance of
bowel prep.
• Cologuard testing could be completed in the
convenience of their homes without Covid-19 risks.
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